- Cellect Biotechnology Ltd. APOP shares surged 24.7 percent to $5.20. Cellect Biotech disclosed that it has treated the first blood cancer patient in Phase I/II trial of ApoGraft
- Kforce Inc. KFRC shares climbed 21.1 percent to $25.85 after the company reported better-than-expected Q4 earnings. Avondale Partners upgraded Kforce from Market Perform to Outperform.
- Wecast Network Inc WCST shares rose 20.4 percent to $1.91.
- Aehr Test Systems AEHR surged 18.6 percent to $2.62 as the company disclosed that it has received an order from a subcontractor to its lead customer for its FOX-XP test and burn-in system products.
- Coherent, Inc. COHR shares climbed 17.5 percent to $189.63 after the company reported better-than-expected Q1 earnings.
- Lumentum Holdings Inc LITE jumped 14.9 percent to $46.18 on better-than-expected quarterly earnings.
- Diffusion Pharmaceuticals Inc DFFN shares surged 14.8 percent to $5.03. Diffusion Pharmaceuticals disclosed that TSC Phase 1/2 glioblastoma multiforme clinical trial results has been published in the February 2017 edition of Journal of Neurosurgery.
- Foundation Medicine Inc FMI shares climbed 13.1 percent to $24.77 in pre-market trading after surging 12.31 percent on Tuesday. Foundation Medicine will release its quarterly earnings on February 22, 2017.
- Caesarstone Ltd CSTE gained 12.7 percent to $33.80. Caesarstone reported Q4 adjusted earnings of $0.53 per share on revenue of $135 million.
- Universal Corp UVV climbed 12 percent to $78.90. Universal Corp reported FQ3 net income of $53.6 million on revenue of $668.8 million.
- OncoSec Medical Inc ONCS rose 11.7 percent to $1.32. OncoSec disclosed that it will present new clinical data from its Phase 2 combination study at ASCO-SITC Clinical Immuno-Oncology Symposium.
- Jive Software Inc JIVE gained 10.8 percent to $4.38 after the company posted upbeat quarterly results.
- Walker & Dunlop, Inc. WD shares surged 10.6 percent to $35.50 after the company posted strong Q4 results.
- Myriad Genetics, Inc. MYGN gained 10.6 percent to $17.03 after the company posted upbeat Q2 results and narrowed its FY17 adjusted earnings outlook. Ladenburg Thalmann upgraded Myriad Genetics from Sell to Neutral.
- ScanSource, Inc. SCSC shares climbed 10 percent to $44.08 on stronger-than-expected quarterl
- y earnings.
- Microchip Technology Inc. MCHP rose 7.6 percent to $74.90 after the company reported upbeat Q3 results and issued a strong Q4 outlook. Needham upgraded Microchip from Buy to Strong Buy.
- Momo Inc (ADR) MOMO gained 7.5 percent to $24.48. Jefferies initiated coverage of Momo with a Buy rating.
- Thor Industries, Inc. THO rose 4.7 percent to $109.38. Baird upgraded Thor Industries from Neutral to Outperform.
- Vanda Pharmaceuticals Inc. VNDA rose 4.1 percent to $14.20. Vanda Pharmaceuticals is expected to announce Q4 financial results on February 15, 2017.
- Cognizant Technology Solutions Corp CTSH shares rose 3.7 percent to $55.76 after the company posted upbeat quarterly earnings and reported a cooperation agreement with Elliott Management.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: NewsIntraday UpdateMarketsAnalyst RatingsMoversInformation TechnologySemiconductorsTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
